LiteFold

245 posts

LiteFold banner
LiteFold

LiteFold

@try_litefold

The infrastructure for Drug Discovery. We are here to make AI for Science more accessible.

Earth Katılım Aralık 2024
11 Takip Edilen2K Takipçiler
Sabitlenmiş Tweet
LiteFold
LiteFold@try_litefold·
Announcing Rosalind, the most versatile AI Co-Scientist for computational biology and therapeutics research. Giving every biologist their own frontier research lab. Make every experiment count. It's live. Links in the comments.
English
23
81
661
51.3K
LiteFold retweetledi
Asimov Press
Asimov Press@AsimovPress·
A few years ago, designing an antibody on the computer was extremely difficult. Today, there are several open-source tools which allow anyone to design antibodies from home. Out today: A step-by-step guide to antibody design. By @btnaughton.
English
6
75
305
46.4K
LiteFold retweetledi
LiteFold
LiteFold@try_litefold·
Onwards and Upwards
Paul Kohlhaas bio/acc@paulkhls

4/ The pipeline isn’t a roadmap. It’s running today: Ai Scientist BIOS by @BioProtocol generates ideas (BixBench leader, super low cost, free to use for academics) → computational validation → quality gates → published on beach dot science → the agent swarm attacks it from every angle → results flow back → strongest work moves into on chain labs and further AI Scientist stack My agent posted a hypothesis on GLP-1s using BIOS. Then I personally built this out using @try_litefold generating 3 novel targets. 4h after sharing the abstract on X, an assistant professor of Cambridge University Institute of Metabolic Science reached out as they have animal models and phenotyping platforms (shared below with consent). We're scoping wet lab validation already and poking holes into the original hypothesis. Specifically, whether biasing toward beta-arrestin recruitment over Gs coupling is good

English
0
2
7
994
LiteFold retweetledi
Paul Kohlhaas bio/acc
Paul Kohlhaas bio/acc@paulkhls·
4/ The pipeline isn’t a roadmap. It’s running today: Ai Scientist BIOS by @BioProtocol generates ideas (BixBench leader, super low cost, free to use for academics) → computational validation → quality gates → published on beach dot science → the agent swarm attacks it from every angle → results flow back → strongest work moves into on chain labs and further AI Scientist stack My agent posted a hypothesis on GLP-1s using BIOS. Then I personally built this out using @try_litefold generating 3 novel targets. 4h after sharing the abstract on X, an assistant professor of Cambridge University Institute of Metabolic Science reached out as they have animal models and phenotyping platforms (shared below with consent). We're scoping wet lab validation already and poking holes into the original hypothesis. Specifically, whether biasing toward beta-arrestin recruitment over Gs coupling is good
Paul Kohlhaas bio/acc tweet media
English
1
3
14
3.3K
LiteFold retweetledi
Anindya
Anindya@anindyadeeps·
I started to read and understand biology by doing plenty of chatgpt deepresearch. One thing I always missed was visuals. Since biology needs to be visual to be understandable. Today I just realized, I can just do that using Rosalind by @try_litefold. This is a really well written introductory blog on how CryoEM data is being studied. Link of the document in the description.
Anindya tweet media
English
2
14
88
7.4K
LiteFold
LiteFold@try_litefold·
You can also generate such beautiful blogs in just one or two prompts. Try this out at: app.litefold.ai
Anindya@anindyadeeps

I started to read and understand biology by doing plenty of chatgpt deepresearch. One thing I always missed was visuals. Since biology needs to be visual to be understandable. Today I just realized, I can just do that using Rosalind by @try_litefold. This is a really well written introductory blog on how CryoEM data is being studied. Link of the document in the description.

English
0
6
22
2.8K
LiteFold retweetledi
Derya Unutmaz, MD
Derya Unutmaz, MD@DeryaTR_·
I've been testing LiteFold. It's an excellent BioAI model!
English
2
13
54
9.9K
LiteFold
LiteFold@try_litefold·
Quick note: this is just a 4-page structured research brief generated from an end-to-end computational run. Not claiming novelty, not replacing peer review. The value is speed and structure. Literature synthesis, pocket detection, docking, and a written summary in one workflow. That layer of scientific execution harness is what we’re building.
LiteFold@try_litefold

We asked Rosalind to explore SARS-CoV-2 Mpro from scratch. It scanned the literature, pulled the 3D structure (6Y2E), detected and ranked binding pockets, prepared nirmatrelvir, ran docking in both the active and an allosteric site, generated PyMOL visualizations, and wrote a structured research brief. The paper is attached below.

English
0
6
25
2.5K
LiteFold retweetledi
LiteFold
LiteFold@try_litefold·
We asked Rosalind to explore SARS-CoV-2 Mpro from scratch. It scanned the literature, pulled the 3D structure (6Y2E), detected and ranked binding pockets, prepared nirmatrelvir, ran docking in both the active and an allosteric site, generated PyMOL visualizations, and wrote a structured research brief. The paper is attached below.
LiteFold tweet media
English
2
7
47
15.4K
LiteFold
LiteFold@try_litefold·
Asked Rosalind to model trastuzumab PK. It downloaded the PDB structure, wrote an R script using mrgsolve, ran a 2-compartment model with real PopPK parameters (Bruno et al. 2005), and gave me Cmax, Ctrough, and a full 24-week PK profile. One prompt. We are coming out with detailed blogs of Rosalind, one capability at a time, very soon.
LiteFold tweet media
English
3
6
65
4.4K
LiteFold
LiteFold@try_litefold·
@MOmunagbe feel free to apply for our credits.
English
1
0
1
97